Chargement en cours...
Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE
Background: Studies 016 and SETTLE showed that safinamide was safe and effective as adjunct therapy in patients with advanced Parkinson’s disease (PD) and motor fluctuations. The addition of safinamide to a stable dose of levodopa alone or with other antiparkinsonian medications significantly increa...
Enregistré dans:
| Publié dans: | J Parkinsons Dis |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
IOS Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927927/ https://ncbi.nlm.nih.gov/pubmed/26889632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-150700 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|